1. Home
  2. MEDP

as of 12-12-2025 3:35pm EST

$559.81
$6.34
-1.12%
Stocks Health Care Biotechnology: Commercial Physical & Biological Resarch Nasdaq

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has more than 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati, Ohio, and its operations are primarily based in the US, with additional presence in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Chart Type:
Time Range:
Founded: 1992 Country:
United States
United States
Employees: N/A City: CINCINNATI
Market Cap: 13.4B IPO Year: 2016
Target Price: $465.18 AVG Volume (30 days): 265.4K
Analyst Decision: Hold Number of Analysts: 12
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 14.32 EPS Growth: 25.36
52 Week Low/High: $250.05 - $626.25 Next Earning Date: 10-22-2025
Revenue: $2,358,373,000 Revenue Growth: 13.88%
Revenue Growth (this year): 21.48% Revenue Growth (next year): 11.90%

AI-Powered MEDP Daily Prediction

Machine learning model trained on 25+ technical indicators

Updated 3 days ago

AI Recommendation

hold
Model Accuracy: 68.42%
68.42%
Confidence

Disclaimer: This prediction is generated by an AI model and should not be considered as financial advice. Always conduct your own research and consult with financial professionals before making investment decisions.

Stock Insider Trading Activity of Medpace Holdings Inc. (MEDP)

MEDP Dec 3, 2025

Avg Cost/Share

$590.69

Shares

668

Total Value

$394,580.92

Owned After

646,184

SEC Form 4

MEDP Dec 2, 2025

Avg Cost/Share

$590.47

Shares

5,698

Total Value

$3,364,498.06

Owned After

646,184

SEC Form 4

MEDP Dec 1, 2025

Avg Cost/Share

$593.25

Shares

23,178

Total Value

$13,750,348.50

Owned After

646,184

SEC Form 4

MEDP Nov 28, 2025

Avg Cost/Share

$593.46

Shares

15,151

Total Value

$8,991,512.46

Owned After

646,184

SEC Form 4

MEDP Nov 26, 2025

Avg Cost/Share

$606.88

Shares

41,331

Total Value

$25,082,957.28

Owned After

646,184

SEC Form 4

MEDP Nov 25, 2025

Avg Cost/Share

$615.52

Shares

42,392

Total Value

$26,093,123.84

Owned After

646,184

SEC Form 4

MEDP Nov 24, 2025

Avg Cost/Share

$607.78

Shares

59,025

Total Value

$35,874,214.50

Owned After

646,184

SEC Form 4

BURWIG SUSAN E

Exec. VP, Operations

Sell
MEDP Nov 24, 2025

Avg Cost/Share

$609.15

Shares

20,000

Total Value

$12,183,000.00

Owned After

27,500

SEC Form 4

MEDP Nov 21, 2025

Avg Cost/Share

$592.18

Shares

21,858

Total Value

$12,943,870.44

Owned After

646,184

SEC Form 4

Brady Kevin M.

CFO & Treasurer

Sell
MEDP Nov 21, 2025

Avg Cost/Share

$590.35

Shares

3,000

Total Value

$1,771,050.00

Owned After

6,000

SEC Form 4

Latest Medpace Holdings Inc. News

MEDP Breaking Stock News: Dive into MEDP Ticker-Specific Updates for Smart Investing

All MEDP News

Share on Social Networks: